Min Min Yang
Vorstandsvorsitzender bei PHARMABLOCK SCIENCES (NANJING), INC.
Vermögen: 179 Mio $ am 31.05.2024
Aktive Positionen von Min Min Yang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Vorsitzender | 01.12.2014 | - |
| Vorstandsvorsitzender | 21.04.2023 | - | |
| Gründer | 26.12.2006 | - | |
| Direktor/Vorstandsmitglied | 01.11.2014 | 01.12.2014 | |
| GEMPHARMATECH CO., LTD. | Direktor/Vorstandsmitglied | 19.10.2023 | - |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.03.2021 | - |
| Independent Dir/Board Member | 01.03.2021 | - |
Karriereverlauf von Min Min Yang
Ausbildung von Min Min Yang
| Nanjing University | Graduate Degree |
| Auburn University | Doctorate Degree |
Statistik
International
| China | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| GEMPHARMATECH CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- Min Min Yang
- Erfahrung
